Connect your AI

CYPH CYPH Strategic investments

Strategic investments at other companies

PfizerPFE

——

Other financials

Income statement

Revenue$375.0K—

Operating income-$4.8M+69.7%

Net income-$77.2M-400%

EPS (diluted)-$0.46-24.3%

Balance sheet

Cash & equivalents$6.7M-79.6%

Total debt$38.0K-75.3%

Total equity$84.4M+305%

Total assets$87.4M+151%

Cash flow

Operating cash flow-$3.4M+76.3%

Valuation

Market cap$65.19M-54.5%

Enterprise value$58.54M—

P/S43.5×—

Profitability

Operating margin-2,761.7%—

Net margin-2,705.8%—

Returns & leverage

Return on equity-108.2%-34.4pp

Debt / equity0×0.0×

Current ratio27.3×+24.9×

Where this comes from

Reported directly by CYPH in its filing.

Tagged under the XBRL concept us-gaap:OtherLongTermInvestments.

The official record: CYPH’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CYPH's strategic investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is CYPH's strategic investments?: CYPH (CYPH) reported strategic investments of $5M in Q1 2026.